Asteria Health Recalls Testosterone and Triamcinolone Acetonide Pellets Due to Potential Metal Contamination

What Happened

F.H. INVESTMENTS, Inc., doing business as Asteria Health, has initiated a voluntary recall of specific sterile pellets. The recall was issued due to the potential presence of a foreign substance, specifically metal particulate matter, within the product. The FDA has classified this as a Class II recall.

Which Products Are Affected

The recall involves 7,840 units of Testosterone 200mg and Triamcinolone Acetonide 40mcg sterile pellets.

• Product Name: Testosterone 200mg, Triamcinolone Acetonide 40mcg, 1 Sterile Pellet
• Brand/Label: Asteria Health (432 Industrial Ln, Birmingham, AL 35211)
• NDC: 79559-6200-43
• Lot Number: 256000105
• Expiration Date: 09/19/2026
• Recall Number: D-0329-2026

These products were distributed nationwide across the United States.

What You Should Do

Consumers and healthcare providers should immediately stop using the affected lot. The firm initiated the recall via notification letters. For further information regarding returns or specific instructions, stakeholders should contact F.H. INVESTMENTS, Inc. (dba Asteria Health) at their Birmingham, Alabama facility.

Why This Matters

The presence of metal particulate matter in a sterile product intended for medical use poses a risk of adverse health consequences, including potential injury or inflammation at the site of administration.

Source

This information is based on official recall data provided by the FDA.